About
Lewis graduated with a BSc (Hons) in Tropical Disease Biology from the University of Liverpool in 2021. He went on to work at the university’s Institute of Infection, Veterinary and Ecological Sciences, before briefly moving to industry as an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) technician.
In 2022, he moved back to the University of Liverpool to join the Antimicrobials for Global Health (AGH) group, where he now supervises the microbiology workflow alongside contributing to the group’s other experimental workstreams. Lewis has worked on various multicentre projects involving academic and industry partners through the evaluation of PK–PD relationships and the development of complex in vitro and in vivo infection models for drug development, optimised dosing, and the suppression of the emergence of resistance to existing and novel combination and monotherapies in preclinical drug development and for enhanced clinical application.